Intent to Sole Source VFA Capital Planning Database Subscription

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA Office of Acquisitions and Grants Services

Contract Value

Not provided

Codes & Classification
Solicitation Number

FDA75F40126Q00173

NAICS

541511 - Custom Computer Programming Services

Classification Code

DH10

Additional Details
Set Aside

NONE

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents1
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Special Notice regarding its intent to sole source a subscription for the VFA Capital Planning Database. This procurement is managed by the FDA Office of Acquisitions and Grants Services, specifically through the Office of the Commissioner’s Engineering Management Branch (EMB). The primary objective of this initiative is to secure a comprehensive facility condition and capital project planning solution that will enable effective management of the FDA’s owned-facility portfolio. The scope of this requirement includes both software licensing and professional support services associated with the VFA database platform. The selected solution must facilitate robust facility condition assessments and support capital project planning activities, ensuring that the FDA can optimize the utilization and maintenance of its facilities. The deliverables are expected to encompass access to the VFA database, as well as ongoing technical and professional support to maximize the platform’s effectiveness. This procurement falls under NAICS Code 541511, which pertains to Custom Computer Programming Services, and is classified with Product Service Code DH10. The place of performance is designated as Silver Spring, Maryland, within the United States. There are no set-aside requirements for this opportunity, indicating that it is open to all qualified vendors without restrictions for small business or other socioeconomic categories. The notice is currently active, with a posting date of May 29, 2026, and a response deadline of June 10, 2026. Interested parties are encouraged to review the attached document titled “Intent to Sole Source FDA-75F40126Q00173” for further details. For additional information or inquiries, the primary point of contact is Terina Hicks, who can be reached via email at [email protected]. Contractors considering this opportunity should note that the FDA seeks a proven, integrated solution for facility and capital planning, with an emphasis on both software and support services. The procurement is intended to ensure continuity and reliability in facility management operations, supporting the agency’s mission-critical infrastructure over the contract lifecycle. Further details and official documentation can be accessed through the SAM.gov opportunity link provided in the notice.